NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Pro-Dex, Inc. (PDEX) Stock Analysis

Pro-Dex, Inc. (PDEX) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PDEX

$60.56

+$1.16 (+1.96%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PDEX with… →

PDEX Key Statistics

As of Oct 21, 2026
Trading
Open
$59.76
Previous Close
$59.40
Day's Range
59.60–60.71
52-Week Range
25.59–77.00
Volume
20.58K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.04
Valuation
Market Cap
$195.80M
P/E Ratio
14.70
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.02
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.52
EPS (ttm)Profit attributable to each share over the last twelve months.
4.12
Financials (FY)
Revenue (FY)
$66.59M+23.68%
Net Income (FY)
$8.98M+322.10%
Profit marginThe share of revenue left as profit after all costs and taxes.
17.62%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.23M
1-Year Return
+132.21%
Dividend and dates
Earnings Date
October 29, 2026estimated
Avg Volume
68.50K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PDEX closed at $60.56, +132.21% over 1 year.

Pro-Dex, Inc. (PDEX) has a market capitalization of $195.80M.

In fiscal 2025, PDEX reported revenue of $66.59M.

PDEX Stock Return by Calendar Year

Pro-Dex, Inc. (PDEX) 10-year return: what $10,000 became

1 year
$10,000 $23,221
+132.21%
5 years
$10,000 $23,984
+139.84%
10 years
$10,000 $128,851
+1,188.51%

If you had invested $10,000 in Pro-Dex, Inc. (PDEX) 10 years ago, at the close on October 21, 2016, it would have been worth $128,851 at the close on October 21, 2026: +1,188.51% in total, +29.12% a year. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+57.38%
2025−17.69%
2024+166.84%
2023+10.19%
2022−31.50%
2021−25.06%
2020+76.47%
2019+45.28%
2018+77.65%
2017+44.68%
2016 (partial year)+1.95%

As of October 21, 2026.

PDEX Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$66.59M$8.98M13.5%
2024$53.84M$2.13M4.0%
2023$46.09M$7.07M15.3%
2022$42.04M$4.57M10.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$66.59M$19.51M$10.69M$8.98M13.5%
2024$53.84M$14.55M$7.17M$2.13M4.0%
2023$46.09M$12.75M$5.76M$7.07M15.3%
2022$42.04M$13.13M$5.16M$4.57M10.9%

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

PDEX Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricPDEXMedical Instruments & Supplies medianvs median
P/E14.7031.1953% below
P/S ratio2.522.603% below
Profit margin17.62%1.62%16.0 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Pro-Dex, Inc. (PDEX) at $195.80M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 201 employees.

Over the past 52 weeks the price has ranged from $25.59 to $77.00. The most recent close on file for PDEX is $60.56, dated October 21, 2026. That is +$1.16 (+1.96%) against the previous close. The latest close sits 136.65% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $66.59M. Against the prior fiscal year total of $53.84M, that is a change of +23.68%. The same year closed with net income of $8.98M. That is +322.10% against the prior fiscal year. Profit margin runs at 17.62%. That is 16 percentage points above the Medical Instruments & Supplies median of 1.62%. Trailing earnings per share are 4.12.

Across the 4 fiscal years on file, revenue moves from $42.04M in 2022 to $66.59M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 14.7. That is 52.87% below the Medical Instruments & Supplies median of 31.19. The forward P/E on file is 18.02. Measured against sales, the shares trade at 2.52 times revenue. On price-to-sales that is 2.8% below the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

The trailing one-year total return is +132.21%. Measured over 10 years, that is +29.12% a year compounded. The reported beta is 0.04. Daily returns over the trailing 10 years annualize to a volatility of 58.25%.

Growth & Income

No dividend is on file for PDEX.

Across the complete calendar years on file, 2024 returned +166.84% and 2022 returned −31.50%. Of the 9 complete calendar years on file, 6 finished higher. So far in 2026 the total return is +57.38%.

Peer Comparison

Pro-Dex, Inc. (PDEX) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Pro-Dex, Inc. PDEX $195.80M 14.7
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Pro-Dex, Inc. trades at a P/E of 14.7.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Pro-Dex, Inc.

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Visit website →